Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | RCEL Avita Medical, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $11.73 -1.9% | $16.31 +6.3% |
| StockIQ Score | 63C+ Moderate Risk: High | 42D Weak Risk: Medium |
| Technical | 79B+ | 36F |
| Fundamental | 37F | 35F |
| Growth | 79B+ | 50C- |
| Fair Value | 38F | 38F |
| News | 100A+ | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 32F | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Avita Medical (RCEL) outperforms Ascentage Pharma (AAPG) in technical and growth scores, both at 79 versus 36 and 50, respectively. Its investor score (63) is also stronger than AAPG’s weak 42. However, AAPG’s valuation score ties at 38, while RCEL’s fundamental score (37) is slightly higher than AAPG’s (35). RCEL has a moderate rating, while AAPG is rated weak.
